COOPER BEIERLE: Open Payments
NPI 1821835703 · SALEM, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,797 in 82 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $271 · 2025 $1,797
Food & beverage: $1,797
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 31 | $925 |
| Collegium Pharmaceutical, Inc. | 22 | $241 |
| PFIZER INC. | 10 | $205 |
| ABBVIE INC. | 10 | $153 |
| TerSera Therapeutics LLC | 1 | $98 |
| Boston Scientific Corporation | 3 | $63 |
| DePuy Synthes Sales Inc. | 2 | $44 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $44 |
| Merz Pharmaceuticals, LLC | 1 | $25 |
Products named: INCEPTIV, SYNCHROMEDII, Belbuca, NURTEC ODT, BOTOX, Prialt, JOURNAVX, Xeomin.
Industry payments across VA — which companies pay providers there.
